Skip to content

A randomized controlled study on the effectiveness of Tianma Gouteng Yin combined with vestibular rehabilitation in the treatment of persistent postural perceptual dizziness based on the theory of "treating from the gods"

A randomized controlled study on the effectiveness of Tianma Gouteng Yin combined with vestibular rehabilitation in the treatment of persistent postural perceptual dizziness based on the theory of "treating from the gods"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000051
Enrollment
Unknown
Registered
2023-09-28
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent postural perceptual dizziness

Interventions

control group:Selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors and vestibular rehabilitation
Treatment group:Modification of Tianma Gouteng Drink and Vestibular Rehabilitation

Sponsors

Jilin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Gender unlimited, aged between 18 and 80 years old; (2) Meets the diagnostic criteria for persistent postural perceptual dizziness, as well as the diagnostic criteria for liver yang hyperactivity syndrome in vertigo; (3) Those who voluntarily participate in this experiment and sign an informed consent form; (4) Having a certain level of education, able to read simple articles and write simple sentences in the past; (5) No severe functional organs or other serious diseases are present.

Exclusion criteria

Exclusion criteria: (1) Individuals with dizziness/dizziness disorders other than Persistent postural perceptual dizziness; (2) Has received or is currently taking anti anxiety/depression medication treatment within the past three months and has an impact on the observed indicators; (3) Patients with other serious internal and external diseases; (4) Patients with allergies or contraindications to the investigational drug; (5) Researchers believe that they are unable to participate in the study due to other reasons; (6) Unable to sign informed consent; (7) Individuals with severe anxiety and depression.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine Syndrome Score Table;

Secondary

MeasureTime frame
Hamilton Depression Scale;Vertigo Disorder Scale; VAS rating;Hamilton Anxiety Scale;

Countries

China

Contacts

Public ContactLi Sun

Jilin University of Traditional Chinese Medicine2023

1085839208@qq.com18948584555

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026